Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Diagnostic Hybrids Inc (AKA: Molecular Diagnostics Inc)
Profile last edited on: 11/1/10      CAGE: 1YDB1      UEI:

Business Identifier: In Vitro and In Vivo Diagnostic Substances
Year Founded
1983
First Award
1984
Latest Award
1986
Program Status
Inactive (Acquired)
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

350 West State Street
Athens, OH 45701
   (740) 593-1784
   scholl@dhiusa.com
   www.dhiusa.com
Location: Single
Congr. District: 15
County: Athens

Public Profile

In January 2010, Diagnostic Hybrids Inc was acquired by Quidel Corporation (NASDAQ:QDEL), Diagnostic Hybrids innovates, develops, manufactures and markets cellular and molecular diagnostic kits for various applications in detecting a wide range of respiratory diseases, herpes infections, and other high value markers of disease.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
1
Conversion Rate
100.00%
Phase I Dollars
$50,000
Phase II Dollars
$298,999
Total Awarded
$348,999

Synopsis: Awardee Business Condition

Employee Range
150-249
Revenue Range
15M-20M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
50-74

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
1986 2 NIH $348,999
Project Title: DNA hybridization in the diagnosis of infectious disease

Key People / Management

  David R Scholl -- President

Company News

There are no news available.